Support the news

Patent Fight Over Gene-Editing Technology CRISPR Heads To Patent Court10:00
Download

Play
Photo of bacterial DNA on a flowcell to be run through a whole-genome sequencing machine called a MiSeq. (David Goldman/AP)
Photo of bacterial DNA on a flowcell to be run through a whole-genome sequencing machine called a MiSeq. (David Goldman/AP)
This article is more than 2 years old.

Three federal patent judges will hear oral arguments Tuesday in a heated dispute over a gene-editing technology known as CRISPR — clustered regularly interspaced short palindromic repeats.

CRISPR is widely hailed as a revolution in biology, making it easier for researchers to tweak genes, like a molecular scissors. We check in with Carey Goldberg on the fight and what's at stake.

Guest

Carey Goldberg, host of WBUR's Commonhealth, which tweets @commonhealth.

This segment aired on December 5, 2016.

Related:

Meghna Chakrabarti Twitter Host, On Point
Meghna Chakrabarti is the host of On Point.

More…

Kathleen McNerney Twitter Senior Producer / Editor, Edify
Kathleen McNerney is senior producer/editor of Edify.

More…

+Join the discussion
TwitterfacebookEmail

Support the news